These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10978398)

  • 1. Effect of high-flux dialysis on the anaemia of haemodialysis patients.
    Locatelli F; Andrulli S; Pecchini F; Pedrini L; Agliata S; Lucchi L; Farina M; La Milia V; Grassi C; Borghi M; Redaelli B; Conte F; Ratto G; Cabiddu G; Grossi C; Modenese R
    Nephrol Dial Transplant; 2000 Sep; 15(9):1399-409. PubMed ID: 10978398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study.
    Basile C; Giordano R; Montanaro A; De Maio PD; De Padova FD; Marangi AL; Semeraro A
    Nephrol Dial Transplant; 2001 Sep; 16(9):1914-9. PubMed ID: 11522879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis adequacy and response to erythropoietic agents: what is the evidence base?
    Locatelli F; Del Vecchio L
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii29-35. PubMed ID: 14607998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit.
    Soffritti S; Russo G; Cantelli S; Gilli G; Catizone L
    BMC Nephrol; 2009 Oct; 10():33. PubMed ID: 19852833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis: its role in optimizing recombinant erythropoietin treatment.
    Locatelli F; Del Vecchio L; Andrulli S
    Nephrol Dial Transplant; 2001; 16 Suppl 7():29-35. PubMed ID: 11590254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
    Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
    Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group.
    Weiss LG; Clyne N; Divino Fihlho J; Frisenette-Fich C; Kurkus J; Svensson B
    Nephrol Dial Transplant; 2000 Dec; 15(12):2014-9. PubMed ID: 11096148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.
    Malyszko J; Drozdz M; Zolkiewicz A; Rutkowski B
    Int Urol Nephrol; 2014 Jan; 46(1):71-82. PubMed ID: 23136027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing dose and mode of renal replacement therapy in anaemia management.
    Locatelli F
    Nephrol Dial Transplant; 2002; 17 Suppl 5():60-5. PubMed ID: 12091610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change from conventional haemodiafiltration to on-line haemodiafiltration.
    Maduell F; del Pozo C; Garcia H; Sanchez L; Hdez-Jaras J; Albero MD; Calvo C; Torregrosa I; Navarro V
    Nephrol Dial Transplant; 1999 May; 14(5):1202-7. PubMed ID: 10344362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
    Levin NW; Fishbane S; Cañedo FV; Zeig S; Nassar GM; Moran JE; Villa G; Beyer U; Oguey D;
    Lancet; 2007 Oct; 370(9596):1415-21. PubMed ID: 17950856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Locatelli F; Pisoni RL; Combe C; Bommer J; Andreucci VE; Piera L; Greenwood R; Feldman HI; Port FK; Held PJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):121-32. PubMed ID: 14671047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.